Tyvaso 0.6 MG refill kit
Ended Awarded
- Contract number
- 36C24526N0283
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $15,746
Award facts
- Contract value 100% obligated
- $15,746.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
United Therapeutics Corp has received a delivery order award valued at $15,746.12 from Veterans Integrated Service Network 5 (VISN 5) for Tyvaso 0.6 mg refill kits, with performance in Bartlett, Tennessee and an ultimate completion date of February 4, 2026. This firm fixed-price delivery order, awarded on January 29, 2026, is issued without a set-aside designation under the General Services Administration's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The award represents a routine procurement of this specialized pharmaceutical product, which is used to treat pulmonary arterial hypertension in the veteran population.
This delivery order is executed under United Therapeutics Corp's single-award Blanket Purchase Agreement with the Department of Veterans Affairs National Acquisition Center, valued at $207.1 million through April 23, 2026. The BPA structure, awarded on April 24, 2025, enables the VA to procure Tyvaso alongside three other critical pharmaceutical products—Unituxin, Remodulin, and Orenitram—at pre-negotiated prices without additional competition. This indefinite delivery vehicle streamlines the Veterans Health Administration's ability to manage supply chains for these specialized medications across multiple VISNs nationwide, supporting the VA's mission to ensure reliable access to essential treatments for veterans with rare and life-threatening conditions.
Quick answers
Who was awarded contract 36C24526N0283?
36C24526N0283 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on January 29, 2026.
How much is contract 36C24526N0283 worth?
The government has obligated $15,746 on 36C24526N0283.
Is contract 36C24526N0283 an order under another contract?
Yes. 36C24526N0283 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0283 competed?
The extent of competition for 36C24526N0283 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award